Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia
Author
McCubrey, James A.
Date
2016-11-03
Citation:
APA:
McCubrey, James A.. (November 2016).
Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/9629
MLA:
McCubrey, James A..
"Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia". .
. (),
November 2016.
April 29, 2024.
http://hdl.handle.net/10342/9629.
Chicago:
McCubrey, James A.,
"Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia," , no.
(November 2016),
http://hdl.handle.net/10342/9629 (accessed
April 29, 2024).
AMA:
McCubrey, James A..
Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia. .
November 2016;
():
.
http://hdl.handle.net/10342/9629. Accessed
April 29, 2024.
Collections